FibroBiologics Inc (FBLG)
2.60
+0.19
(+7.88%)
USD |
NASDAQ |
Nov 22, 16:00
2.59
-0.01
(-0.38%)
After-Hours: 20:00
FibroBiologics Total Assets (Quarterly): 10.47M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.47M |
| June 30, 2024 | 8.912M |
| March 31, 2024 | 11.40M |
| December 31, 2023 | 11.82M |
| Date | Value |
|---|---|
| September 30, 2023 | 13.30M |
| June 30, 2023 | 13.84M |
| December 31, 2022 | 4.824M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.824M
Minimum
Dec 2022
13.84M
Maximum
Jun 2023
10.65M
Average
11.40M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 8.004B |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.732M |
| Shareholders Equity (Quarterly) | 2.737M |